摘要： 中国研究者在过去两年有多篇脑卒中一级预防高质量研究成果发表在国外相关专业杂志上，内容涉及缺血性卒中一级预防现状、华法林治疗心房颤动、血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体阻断剂与糖尿病患者预后的关系、补充维生素B 以降低血浆同型半胱氨酸水平与脑血管病风险、非高密度脂蛋白胆固醇与无症状性颅内动脉狭窄的关系、气功预防脑卒中随机对照临床试验等，本文对上述研究进行简要概述。

关键词: 卒中, 一级预防, 中国, 综述

Abstract: Chinese researchers have published some studies in English journals in the past 2 years. These studies focused on status and costs of primary prevention for stroke, warfarin for atrial fibrillation (AF), angiotensin converting enzyme inhibitor (ACEI) and angiotensin Ⅱ receptor blocker (ARB) for diabetes mellitus, vitamin B supplementation for reducing plasm homocysteine level and the risk of cerebrovascular disease, non-high-density lipoprotein cholesterol (non-HDL-C) levels and asymptomatic intracranial arterial stenosis, and Qigong exercises for the prevention of stroke. In this review, we outline the data on primary prevention for stroke and review the risk factors and their management.

Key words: Stroke, Primary prevention, China, Review